CLINICAL TRIALS PROFILE FOR NUCALA
✉ Email this page to a colleague
All Clinical Trials for NUCALA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | GlaxoSmithKline | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | Inner-City Asthma Consortium | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | Rho Federal Systems Division, Inc. | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03292588 ↗ | A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2017-11-07 | The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks. |
NCT03494881 ↗ | Mepolizumab for the Treatment of Chronic Spontaneous Urticaria | Recruiting | GlaxoSmithKline | Early Phase 1 | 2019-07-30 | This is an exploratory study designed to generate preliminary data in evaluating the efficacy of Nucala in the treatment of chronic spontaneous urticaria. |
NCT03494881 ↗ | Mepolizumab for the Treatment of Chronic Spontaneous Urticaria | Recruiting | Mayo Clinic | Early Phase 1 | 2019-07-30 | This is an exploratory study designed to generate preliminary data in evaluating the efficacy of Nucala in the treatment of chronic spontaneous urticaria. |
NCT03656380 ↗ | Mepo for EoE Study | Recruiting | GlaxoSmithKline | Phase 2 | 2019-03-20 | Multi-center, randomized, double blind, parallel-arm, placebo controlled trial to determine whether mepolizumab is more effective than placebo for improving symptoms of dysphagia and decreasing esophageal eosinophil counts in adults and adolescents with active eosinophilic esophagitis after an initial 3 month treatment course, and will also assess the impact of an additional 3 months of treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NUCALA
Condition Name
Clinical Trial Locations for NUCALA
Trials by Country
Clinical Trial Progress for NUCALA
Clinical Trial Phase
Clinical Trial Sponsors for NUCALA
Sponsor Name